Avoro Capital Advisors LLC
CIK 1633313 · Holdings on Jun 30, 2026 · First reported Aug 14, 2026
Top ten holdings
Q2 2026- UTHR13.52%
- ASND12.24%
- KRYS9.64%
- MDGL8.84%
- ARGX8.33%
- ARWR8.31%
- KYMR7.70%
- RVMD3.86%
- CYTK3.82%
- CELC3.19%
Share classes counted separately79.45%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- KRYSWeight increased · +2.29 pp7.35% → 9.64%Shares 0 (0.00%)
- DFTXWeight increased · +2.11 pp0.93% → 3.04%Shares +2.19M (+43.78%)
- UTHRWeight decreased · -1.84 pp15.36% → 13.52%Shares +147.78K (+5.62%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 26
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | UTHRUNITED THERAPEUTICS CORPCommon View history and evidence | $1.51B | 13.52% | 2.78M shares | 15.36% → 13.52%-1.84 pp +147.78K (+5.62%) | Added | ▾ |
| 02 | ASNDASCENDIS PHARMA A/SORDINARY SHARES View history and evidence | $1.36B | 12.24% | 5.11M shares | Prior unavailable — | CUSIP change | ▾ |
| 03 | KRYSKRYSTAL BIOTECH INCCommon View history and evidence | $1.07B | 9.64% | 2.89M shares | 7.35% → 9.64%+2.29 pp 0 (0.00%) | Unchanged | ▾ |
| 04 | MDGLMADRIGAL PHARMACEUTICALS INCCommon View history and evidence | $984.41M | 8.84% | 1.83M shares | 9.38% → 8.84%-0.54 pp +15.15K (+0.83%) | Added | ▾ |
| 05 | ARGXARGENX SE - ADRSponsored ADR View history and evidence | $927.77M | 8.33% | 1.00M shares | 7.19% → 8.33%+1.14 pp 0 (0.00%) | Unchanged | ▾ |
| 06 | ARWRARROWHEAD PHARMACEUTICALS INCommon View history and evidence | $925.59M | 8.31% | 11.36M shares | 6.61% → 8.31%+1.70 pp +655.56K (+6.13%) | Added | ▾ |
| 07 | KYMRKYMERA THERAPEUTICS INCCommon View history and evidence | $857.13M | 7.70% | 7.47M shares | 6.13% → 7.70%+1.57 pp 0 (0.00%) | Unchanged | ▾ |
| 08 | RVMDREVOLUTION MEDICINES INCCommon View history and evidence | $430.18M | 3.86% | 2.30M shares | 2.25% → 3.86%+1.61 pp -47.44K (-2.02%) | Reduced | ▾ |
| 09 | CYTKCYTOKINETICS INCCommon View history and evidence | $425.95M | 3.82% | 5.00M shares | 2.16% → 3.82%+1.66 pp +1.67M (+50.00%) | Added | ▾ |
| 10 | CELCCELCUITY INCCommon View history and evidence | $355.71M | 3.19% | 3.40M shares | 3.79% → 3.19%-0.60 pp +25.00K (+0.74%) | Added | ▾ |
Options overlay 0
No options reported this quarter.
Exited positions 8
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| APLS APELLIS PHARMACEUTICALS INC | Non-derivative | -12,222,222 | -$491.70M | SEC filing ↗ | SEC filing ↗ |
| CNTA CENTESSA PHARMACEUTICALS-ADR | Non-derivative | -11,430,455 | -$454.02M | SEC filing ↗ | SEC filing ↗ |
| TERN TERNS PHARMACEUTICALS INC | Non-derivative | -5,695,000 | -$300.24M | SEC filing ↗ | SEC filing ↗ |
3 / 8 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1633313 · Period 2026-06-30
Data loaded 2026-09-23 · First reported 2026-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 11136250185
}Take these holdings further.
This page includes 26 of 26 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 26 of 26 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1633313","quarter":"2026Q2","page_size":100}
get_institutional_manager_history
{"cik":"1633313","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.